help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lobo, R. A.
Right arrow Articles by Marrs, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lobo, R. A.
Right arrow Articles by Marrs, R. P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHORIONIC GONADOTROPIN
*CLOMIPHENE
*ESTRADIOL
*PROGESTERONE
*TESTOSTERONE

Journal of Clinical Endocrinology & Metabolism, Vol 60, 81-87, Copyright © 1985 by Endocrine Society


ARTICLES

Follicular fluid steroid levels in dysmature and mature follicles from spontaneous and hyperstimulated cycles in normal and anovulatory women

RA Lobo, GS diZerega and RP Marrs

Follicular maturity and atresia have been defined previously, both hormonally and microscopically, in normal ovulatory women. Ovarian hyperstimulation with clomiphene citrate and human menopausal gonadotropins in normal women is carried out for the purpose of aspirating oocytes from several large follicles for in vitro fertilization. Alterations in follicular fluid (FF) hormone levels occur with hyperstimulation regimens, and some of these large follicles (greater than 18 mm) appear morphologically atretic. We have used the term dysmature to describe those large follicles that have an abnormal oocyte morphological appearance and cannot be fertilized in vitro. Mature follicles have been defined by their size, their oocyte morphological appearance, and their ability to be fertilized in vitro. FF from small (2-3 mm) and large (greater than 18 mm) mature and dysmature follicles were obtained from 10 untreated ovulatory women. Mature and dysmature follicles also were obtained from clomiphene and human menopausal gonadotropin-treated normal (n = 11) and anovulatory (n = 5) women. In untreated cycles, the FF steroid content of the small follicles characterized these follicles to be atretic. FF from dysmature follicles from spontaneous untreated cycles had higher concentrations of dihydrotestosterone, 5 alpha-androstane-3 alpha,17 beta-diol, and 17 beta-estradiol (E2) and lower progesterone (Prog) and Prog to E2 ratios (P less than 0.05). Compared to mature follicles from untreated patients, hyperstimulated mature follicles from ovulatory women had higher FF E2 concentrations and lower Prog to E2 ratios (P less than 0.05). In ovulatory patients, the FF concentrations of testosterone were higher and FF Prog and Prog to E2 ratios were lower (P less than 0.05) in the dysmature than in the mature follicles. Mature follicles from hyperstimulated ovulatory patients and those from hyperstimulated anovulatory patients were similar except for lower FF Prog, higher FF E2, and lower Prog to E2 ratios in the anovulatory group. Dysmature follicles from hyperstimulated anovulatory patients had lower FF androstenedione and dihydrotestosterone, but were generally similar to mature follicles. The percentages of dysmature follicles occurring among all large (greater than 18 mm) follicles that were aspirated were similar in ovulatory (34%) and anovulatory (45%) patients. FF steroid concentrations did not correlate with serum levels of testosterone and E2 at the time of follicle aspiration in any patient group. In conclusion, FF androgen concentrations in hyperstimulated follicles were unrelated to morphological maturity.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
A. J. Zeleznik, L. Little-Ihrig, and S. Ramasawamy
Administration of Dihydrotestosterone to Rhesus Monkeys Inhibits Gonadotropin-Stimulated Ovarian Steroidogenesis
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 860 - 866.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R.D. Schramm and B.D. Bavister
A macaque model for studying mechanisms controlling oocyte development and maturation in human and non-human primates
Hum. Reprod., October 1, 1999; 14(10): 2544 - 2555.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Luconi, M. Muratori, G. Forti, and E. Baldi
Identification and Characterization of a Novel Functional Estrogen Receptor on Human Sperm Membrane That Interferes with Progesterone Effects
J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1670 - 1678.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
C. Mendoza, N. Cremades, E. Ruiz-Requena, F. Martinez, E. Ortega, S. Bernabeu, and J. Tesarik
Relationship between fertilization results after intracytoplasmic sperm injection, and intrafollicular steroid, pituitary hormone and cytokine concentrations
Hum. Reprod., March 1, 1999; 14(3): 628 - 635.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
G. C. Wolf, C. R. Sanborn, J. Thompson, L. M. Wagley, H. Mizuma, and C. W. Hilton
Identification of Cyclo(His-Pro)-Like Immunoreactivity in Human Follicular Fluid: Correlation With Steroid and Peptide Hormones
Reproductive Sciences, July 1, 1994; 1(3): 220 - 224.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1985 by The Endocrine Society